Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
KA - Kineta Inc - Stock Price Chart
TickerKA [NASD]
CompanyKineta Inc
CountryUSA
IndustryBiotechnology
Market Cap42.69MEPS (ttm)-20.85
P/E-EPS this Y87.65%
Forward P/E-EPS next Y9.43%
PEG-EPS past 5Y47.65%
P/S8.82EPS next 5Y-
P/B5.67EPS Q/Q-
Dividend-Sales Q/Q404.50%
Insider Own32.95%Inst Own13.66%
Insider Trans1.26%Inst Trans-14.18%
Short Float0.53%EarningsAug 11/a
Analyst Recom1.00Target Price8.00
Avg Volume26.61K52W Range1.78 - 15.54
Today 08:30AM Kineta Announces Positive KVA12123 Monotherapy Safety and Biomarker Data from its Ongoing Phase 1/2 VISTA-101 Clinical Trial (GlobeNewswire)
Sep-28-23 09:30AM Kineta Announces Participation at October Investor Conferences (GlobeNewswire) +13.87%
Sep-25-23 09:30AM Kineta to Present New Preclinical Data on Lead Anti-CD27 Agonist Antibody at AACR Special Conference on Tumor Immunology and Immunotherapy (GlobeNewswire) +8.26%
Sep-18-23 09:30AM Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression (GlobeNewswire) +14.51%
Sep-16-23 09:00PM Insider Buying: Thierry Guillaudeux Acquires 10,000 Shares of Kineta Inc (GuruFocus.com)
Aug-31-23 09:30AM Kineta to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-16-23 06:44AM KA: Second Quarter Results (Zacks)
Aug-11-23 04:07PM Kineta: Q2 Earnings Snapshot (AP Finance) +6.51%
04:01PM Kineta Reports Second Quarter 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
Aug-04-23 06:23AM Force Webinar: Kineta, Ushering In A New Era Of Immunotherapy (Zacks Small Cap Research) -5.26%
IMMX - Immix Biopharma Inc - Stock Price Chart
TickerIMMX [NASD]
CompanyImmix Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap86.59MEPS (ttm)-0.81
P/E-EPS this Y-36.81%
Forward P/E-EPS next Y-6.36%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B5.41EPS Q/Q-111.19%
Dividend-Sales Q/Q-
Insider Own74.19%Inst Own3.23%
Insider Trans1.00%Inst Trans33.19%
Short Float1.42%Earnings-
Analyst Recom1.00Target Price11.00
Avg Volume167.08K52W Range0.68 - 4.51
Today 09:14AM Immix Biopharma Announces Complete Response in 9th Relapsed/Refractory AL Amyloidosis Patient in NXC-201 Clinical Trial at IMS 20th Annual Meeting (GlobeNewswire)
Oct-02-23 08:06AM Immix Biopharma Announces 72-Patient NXC-201 Clinical Data at the IMS 20th Annual Meeting, 95% Overall Response Rate in Multiple Myeloma (GlobeNewswire) +26.61%
Sep-22-23 12:04PM Immix (IMMX) Up on Orphan Drug Tag for AL Amyloidosis Therapy (Zacks)
Sep-21-23 08:55AM U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Amyloid Light Chain (AL) Amyloidosis (GlobeNewswire) +15.38%
Sep-19-23 09:10AM Immix Biopharma Subsidiary Nexcella Completes 2nd NXC-201 Engineering Batch at its U.S. CAR-T Manufacturing Site (GlobeNewswire) +24.15%
Sep-15-23 01:18PM Director Helen Adams Buys 13,000 Shares of Immix Biopharma Inc (IMMX) (GuruFocus.com) +5.12%
Sep-07-23 10:38AM The 3 Best Speculative Stocks to Buy Now: September 2023 (InvestorPlace)
08:41AM Nexcella, Immix Biopharma Subsidiary, to Present at the Bank of America 2023 Healthcare Trailblazers Private Company Conference (GlobeNewswire)
Sep-01-23 08:39AM Immix Biopharma Announces Dr. Suzanne Lentzsch, Director of the Multiple Myeloma and Amyloidosis Program at the College of Physicians and Surgeons of Columbia University and at New York Presbyterian Hospital in New York, Joins Scientific Advisory Board (GlobeNewswire) +12.81%
Aug-23-23 08:37AM U.S. Food and Drug Administration Approves Orphan Drug Designation for Immix Biopharma NXC-201 as a Treatment for Multiple Myeloma (GlobeNewswire) +11.11%
EUDA - Euda Health Holdings Limited - Stock Price Chart
TickerEUDA [NASD]
CompanyEuda Health Holdings Limited
CountrySingapore
IndustryHealth Information Services
Market Cap30.49MEPS (ttm)-0.14
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.20EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own34.37%Inst Own10.76%
Insider Trans0.00%Inst Trans0.61%
Short Float0.06%Earnings-
Analyst Recom-Target Price-
Avg Volume219.75K52W Range0.43 - 10.50
Sep-22-23 08:00AM EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Markets Continued Listing Requirements (GlobeNewswire)
Aug-14-23 08:15AM EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Requirement (GlobeNewswire)
Aug-04-23 08:30AM EUDA Health Holdings Limited Receives Nasdaq Notification Regarding Minimum Market Value Deficiency (GlobeNewswire)
May-19-23 04:05PM EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter (PR Newswire)
Apr-10-23 04:15PM EUDA Health Holdings Limited Announces Receipt of Nasdaq Listing Delinquency Letter (PR Newswire)
Mar-14-23 07:08AM EUDA Health Holdings (NASDAQ:EUDA) shareholders are up 42% this past week, but still in the red over the last year (Simply Wall St.)
Nov-23-22 04:32PM 8i Acquisition 2 Corp. and EUDA Health Ltd Complete Business Combination (GlobeNewswire) -15.09%
FEMY - Femasys Inc - Stock Price Chart
TickerFEMY [NASD]
CompanyFemasys Inc
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap42.05MEPS (ttm)-0.97
P/E-EPS this Y10.68%
Forward P/E-EPS next Y43.15%
PEG-EPS past 5Y-
P/S35.04EPS next 5Y-
P/B3.27EPS Q/Q0.99%
Dividend-Sales Q/Q5.74%
Insider Own11.20%Inst Own7.51%
Insider Trans0.00%Inst Trans14.31%
Short Float0.60%EarningsAug 10/b
Analyst Recom1.00Target Price7.75
Avg Volume11.24M52W Range0.25 - 4.75
Today 08:30AM Femasys Inc. MDSAP Surveillance Audit Successfully Completed (GlobeNewswire) -28.28%
Sep-27-23 08:00AM Femasys Inc. Expands FemBloc Pivotal Trial Enrollment Securing First Academic Site to Participate (GlobeNewswire) -25.00%
Sep-25-23 05:25PM Femasys Inc. Receives U.S. FDA Clearance to Market FemaSeed, an Innovative Infertility Treatment Solution (GlobeNewswire) +6.97%
Sep-20-23 08:30AM Femasys Announces First-Patient-In for Pivotal Clinical Trial Evaluating its FemBloc Permanent Birth Control (GlobeNewswire)
Sep-06-23 08:30AM Femasys to Participate in the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-31-23 08:30AM Femasys Inc. Obtains Medical Device Establishment License from Health Canada (GlobeNewswire)
Aug-10-23 08:00AM Femasys Inc. Announces Financial Results for the Second Quarter Ended June 30, 2023 and Provides Corporate Update (GlobeNewswire) -6.50%
Aug-03-23 08:45AM Femasys Initiates Enrollment in Pivotal Trial of its Permanent Birth Control Candidate FemBloc (GlobeNewswire)
Jul-27-23 08:45AM Femasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemBloc for Female Permanent Birth Control (GlobeNewswire) +130.77%
Jul-03-23 09:55AM Bears are Losing Control Over Femasys Inc. (FEMY), Here's Why It's a 'Buy' Now (Zacks)
ALXO - Alx Oncology Holdings Inc - Stock Price Chart
TickerALXO [NASD, RUT]
CompanyAlx Oncology Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap295.25MEPS (ttm)-3.19
P/E-EPS this Y-4.40%
Forward P/E-EPS next Y-5.58%
PEG-EPS past 5Y-58.82%
P/S-EPS next 5Y-
P/B1.38EPS Q/Q-3.29%
Dividend-Sales Q/Q-
Insider Own55.28%Inst Own44.42%
Insider Trans-0.06%Inst Trans1.24%
Short Float16.48%EarningsAug 10/a
Analyst Recom1.33Target Price27.83
Avg Volume160.07K52W Range3.94 - 13.64
Today 06:00AM ALX Oncology Reports Positive Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer (GlobeNewswire) +49.17%
04:46AM Point Biopharma, ALX Oncology surge premarket; McCormick, Airbnb falls (Investing.com)
Oct-02-23 04:05PM ALX Oncology to Host Investor Call and Webcast on October 3, 2023 to Share Interim Phase 2 ASPEN-06 Clinical Trial Results of Evorpacept for the Treatment of Advanced HER2-Positive Gastric Cancer (GlobeNewswire)
Sep-06-23 08:00AM ALX Oncology Realigns Executive Leadership Team (GlobeNewswire) +6.37%
Aug-31-23 07:00AM ALX Oncology Announces September Investor Conference Participation (GlobeNewswire)
Aug-14-23 07:31PM While dollars continue to flow into biotech, companies cut more jobs (American City Business Journals)
Aug-10-23 04:01PM ALX Oncology Reports Second Quarter 2023 Financial Results and Provides Clinical Program Update (GlobeNewswire)
09:55AM ALX Oncology Holdings Inc. (ALXO) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? (Zacks)
Jun-26-23 07:00AM ALX Oncology Receives Orphan Drug Designation from the European Commission for Evorpacept for the Treatment of Patients with Gastric Cancer (GlobeNewswire)
May-11-23 04:01PM ALX Oncology Reports First Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights (GlobeNewswire)
SASI - Sigma Additive Solutions Inc - Stock Price Chart
TickerSASI [NASD]
CompanySigma Additive Solutions Inc
CountryUSA
IndustryInformation Technology Services
Market Cap1.63MEPS (ttm)-13.87
P/E-EPS this Y49.40%
Forward P/E1.67EPS next Y-
PEG-EPS past 5Y39.22%
P/S2.85EPS next 5Y-
P/B0.68EPS Q/Q43.17%
Dividend-Sales Q/Q-58.99%
Insider Own0.93%Inst Own9.51%
Insider Trans0.00%Inst Trans-
Short Float2.90%EarningsAug 14/a
Analyst Recom1.00Target Price20.00
Avg Volume90.58K52W Range2.77 - 18.90
Sep-21-23 08:31AM Sigma Additive Solutions, Inc. Announces Reverse Stock Split to Regain Nasdaq Compliance and Facilitate Recently Announced Strategic Transactions (ACCESSWIRE) +7.20%
Sep-07-23 08:31AM Sigma Additive Solutions Announces LOIs to Acquire Travel Technology Innovator NextTrip and Sell Assets of Quality Assurance Software to Strategic Buyer (Business Wire) +23.40%
Aug-14-23 04:20PM Sigma Additive Solutions Reports Second Quarter 2023 Financial Results (ACCESSWIRE) -8.82%
Aug-04-23 04:51PM 3 Cheap Stocks to Buy Under $1 in August 2023 (InvestorPlace)
May-18-23 09:55AM Bears are Losing Control Over Sigma Additive Solutions, Inc. (SASI), Here's Why It's a 'Buy' Now (Zacks)
May-15-23 05:15PM Sigma Additive Solutions, Inc. (SASI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:01PM Sigma Additive Solutions Reports First Quarter 2023 Financial Results (ACCESSWIRE)
May-04-23 08:31AM Sigma Additive Solutions to Report First Quarter 2023 Financial Results on Monday May 15, 2023 (Business Wire)
Apr-04-23 12:32PM Sigma Labs, Inc. (NASDAQ:SASI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-30-23 05:25PM Sigma Additive Solutions, Inc. (SASI) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
FORA - Forian Inc. - Stock Price Chart
TickerFORA [NASD]
CompanyForian Inc.
CountryUSA
IndustryHealth Information Services
Market Cap68.26MEPS (ttm)-0.46
P/E-EPS this Y81.48%
Forward P/E-EPS next Y33.33%
PEG-EPS past 5Y-
P/S2.75EPS next 5Y-
P/B3.27EPS Q/Q79.52%
Dividend-Sales Q/Q-25.11%
Insider Own49.38%Inst Own12.65%
Insider Trans0.28%Inst Trans-4.79%
Short Float2.06%EarningsAug 10/a
Analyst Recom1.00Target Price9.00
Avg Volume7.60K52W Range2.00 - 5.45
Aug-13-23 06:29AM Forian Inc. (NASDAQ:FORA) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 04:00PM Forian Inc. Announces Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-26-23 04:00PM Forian Inc. to Announce Second Quarter 2023 Results on August 10, 2023 (GlobeNewswire) +6.23%
Jun-13-23 08:00AM Sidoti Events, LLC's Virtual June Small-Cap Conference (ACCESSWIRE)
May-12-23 04:00PM Forian Inc. Announces First Quarter 2023 Financial Results (GlobeNewswire)
May-01-23 11:00AM Forian Inc. to Announce First Quarter 2023 Results on May 12, 2023 (GlobeNewswire)
Mar-30-23 11:27AM Forian Inc. (NASDAQ:FORA) Q4 2022 Earnings Call Transcript (Insider Monkey) +10.47%
Mar-27-23 04:15PM Forian Inc. Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Mar-14-23 11:30AM Forian Inc. to Announce Fourth Quarter and Full Year 2022 Results on March 27, 2023 (GlobeNewswire)
Feb-13-23 09:05AM Forian Announces the Sale of BioTrack to Alleaves (GlobeNewswire) +15.55%
GRCL - Gracell Biotechnologies Inc ADR - Stock Price Chart
TickerGRCL [NASD]
CompanyGracell Biotechnologies Inc ADR
CountryChina
IndustryBiotechnology
Market Cap249.37MEPS (ttm)-1.28
P/E-EPS this Y17.64%
Forward P/E-EPS next Y-8.65%
PEG-EPS past 5Y-68.83%
P/S-EPS next 5Y-
P/B1.13EPS Q/Q6.03%
Dividend-Sales Q/Q-
Insider Own13.98%Inst Own28.74%
Insider Trans0.00%Inst Trans-4.29%
Short Float1.12%EarningsAug 14/b
Analyst Recom1.00Target Price12.71
Avg Volume246.22K52W Range1.40 - 6.99
Sep-27-23 08:30AM Gracell Biotechnologies Reports Updated Clinical Data for FasTCAR-T GC012F for High-Risk, Newly Diagnosed Multiple Myeloma, Demonstrating 100% Stringent Complete Response Rate (GlobeNewswire)
Sep-26-23 04:00PM Gracell Biotechnologies Doses First Patient in Phase 1b/2 Clinical Trial in U.S. Evaluating GC012F for Treatment of Relapsed/Refractory Multiple Myeloma (GlobeNewswire)
Sep-19-23 09:21AM Gracell Biotechnologies CEO Dr. William Cao Named to Prestigious PharmaVoice 100, Honoring Most Inspiring Life Science Leaders (GlobeNewswire)
Sep-14-23 09:15AM Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences (GlobeNewswire)
Sep-12-23 09:55AM Gracell Biotechnologies Inc. Sponsored ADR (GRCL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks) -6.06%
Sep-06-23 08:00AM Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting FasTCAR-T GC012F in Newly Diagnosed Multiple Myeloma at the 2023 International Myeloma Society Annual Meeting (PR Newswire)
Aug-24-23 04:10PM Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Aug-21-23 09:02PM RA Capital Management, L.P. Acquires Significant Stake in Gracell Biotechnologies Inc. (GuruFocus.com)
Aug-15-23 12:51AM Q2 2023 Gracell Biotechnologies Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-14-23 07:15AM Gracell Biotechnologies Reports Second Quarter 2023 Unaudited Financial Results and Provides Corporate Update (GlobeNewswire)
FFIE - Faraday Future Intelligent Electric Inc - Stock Price Chart
TickerFFIE [NASD]
CompanyFaraday Future Intelligent Electric Inc
CountryUSA
IndustryAuto Manufacturers
Market Cap20.65MEPS (ttm)-1.05
P/E-EPS this Y78.00%
Forward P/E-EPS next Y45.45%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.07EPS Q/Q99.70%
Dividend-Sales Q/Q-
Insider Own7.60%Inst Own6.74%
Insider Trans0.00%Inst Trans-90.61%
Short Float25.19%EarningsAug 21/a
Analyst Recom-Target Price-
Avg Volume3.24M52W Range1.17 - 105.60
Oct-02-23 03:41AM Faraday Future Announces Latest FF 91 2.0 Futurist Alliance Delivery (Business Wire) -10.15%
Sep-29-23 12:11AM Faraday Future Announces its Outline for October FF 91 2.0 Deliveries as Part of its Ongoing Delivery Co-Creation Day Plan and Provides Business Update (Business Wire)
Sep-27-23 07:59PM Faraday Future to Host Investor Presentation Webcast (Business Wire) -44.31%
06:10AM Faraday Future Announces At-the-Market Equity Offering Program (Business Wire)
Sep-25-23 10:22PM Faraday Future Appoints Scott Graziano, Senior Legal Executive with Extensive U.S. Public Company Experience, as Global General Counsel (Business Wire) -24.23%
Sep-21-23 06:10PM Faraday Future Announces Management Stock Purchase Plan (Business Wire) -6.15%
04:30PM Faraday Future Announces Appointment of Matthias Aydt as Global Chief Executive Officer (Business Wire)
Sep-20-23 05:45AM Faraday Future Continues Deliveries, Today Delivering to Kelvin Sherman during the "919 Developers AI Co-Creation Festival", Announces its First Female User and Developer Co-Creation Officer Emma Hernan, and Regaining Nasdaq Compliance (Business Wire)
Sep-15-23 04:05AM Faraday Future to Deliver Another FF 91 2.0 Futurist Alliance, This Time to Celebrity Agent Kelvin Sherman at the Upcoming "919 Developers AI Co-Creation Festival" Taking Place on Sept. 19th (Business Wire) +8.84%
Sep-14-23 04:06AM Faraday Future Delivered Its Vehicle to Realtor and Netflix Star Jason Oppenheim at the "Delivery Co-Creation Day", Creating Boundary-Breaking Eco-Chemistry Among Ultra Luxury Homes, Ultra Luxury Cars, and Reality TV Show Industries (Business Wire) -8.30%
BIMI - BIMI International Medical Inc - Stock Price Chart
TickerBIMI [NASD]
CompanyBIMI International Medical Inc
CountryUSA
IndustryPharmaceutical Retailers
Market Cap6.83MEPS (ttm)-180.63
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y5.28%
P/S0.36EPS next 5Y-
P/B0.83EPS Q/Q99.87%
Dividend-Sales Q/Q70.33%
Insider Own31.93%Inst Own0.14%
Insider Trans0.00%Inst Trans20.95%
Short Float11.05%Earnings-
Analyst Recom-Target Price-
Avg Volume87.48K52W Range0.48 - 4.44
Sep-22-23 09:00AM BIMI International Medical Inc. Announces Subsidiary Phenix Bio Incs Appointment of ASEAN Exclusive Distributor (GlobeNewswire)
Aug-24-23 09:25AM BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) (GlobeNewswire) -7.97%
Aug-07-23 08:00AM BIMI International Medical Inc. Announces Strategic Partnership by its Phenix Bio Inc. Subsidiary with China Duty Free Group (GlobeNewswire) -11.96%
May-22-23 09:25AM BIMI International Medical Inc. Announces First Quarter 2023 Financial Results (GlobeNewswire) +19.82%
May-06-23 08:19AM BIMI International Medical Full Year 2022 Earnings: US$8.15 loss per share (vs US$65.24 loss in FY 2021) (Simply Wall St.)
Apr-20-23 06:00AM BIMI Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) (GlobeNewswire) +8.37%
Apr-19-23 07:32AM BIMI Announces Results of 2023 Special meeting of Shareholders. (GlobeNewswire)
Dec-13-22 04:30PM BIMI Announces Entry into a Material Definitive Agreement (GlobeNewswire) -7.59%
Dec-08-22 05:00PM BIMI Announces Sale of $2 Million Promissory Note (GlobeNewswire) -9.07%
05:00PM BIMI Announces 1-for -10 Reverse Stock Split (GlobeNewswire)
1234567⋯10⋯20
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2023 FINVIZ.com. All Rights Reserved.